Ticker brief
CGTX
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
8
authors 14d
6
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-19 → 2026-06-27 · now -0.35 (−1 bearish … +1 bullish)
Who spoke6
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @BPharmCatalyst | C | · | 2 | +0.00 |
| @BiopharmIQ | B | · | 2 | -0.42 |
| @Analytica_X | B | -1.08 | 1 | +0.35 |
| @BioStocks | C | -0.39 | 1 | +0.45 |
| @CrweWorld | C | · | 1 | +0.30 |
| @OzmosiHealth | C | · | 1 | +0.30 |
Recent signals8of 8 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-06-27 | @BiopharmIQ | -0.35 | Weekly biotech move list with percentage gainers and losers, capped to six tickers. | · | tweet ↗ |
| 2026-06-24 | @BiopharmIQ | -0.50 | Biotech stock moves list with key percentage moves and associated news headlines. | · | tweet ↗ |
| 2026-06-24 | @OzmosiHealth | +0.30 | Cognition aligns with FDA on pivotal study aspects after meeting minutes. | · | tweet ↗ |
| 2026-06-24 | @CrweWorld | +0.30 | Cognition aligns on pivotal study aspects after FDA meeting minutes. | · | tweet ↗ |
| 2026-06-24 | @BioStocks | +0.45 | FDA agreed DLB psychosis could be approvable outcome and aligned on pivotal trial aspects. | · | tweet ↗ |
| 2026-06-23 | @Analytica_X | +0.35 | Lists top gainers and catalysts, including GETY partnership with OpenAI. | · | tweet ↗ |
| 2026-06-19 | @BPharmCatalyst | +0.00 | Biotech watchlist calendar names tickers but gives no stance. | · | tweet ↗ |
| 2026-06-19 | @BPharmCatalyst | +0.00 | Weekly biotech watchlist lists tickers without specific stance. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.